|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.20 GBX | -1.70% |
|
+8.88% | +7.87% |
| 07-28 | Essentra plc, H1 2026 Earnings Call, Jul 28, 2026 | |
| 07-28 | EARNINGS AND TRADING: Allergy Therapeutics names next executive chair | AN |
Company Valuation: Essentra plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,038 | 712 | 488.3 | 381.3 | 275 | 295.5 | - | - |
| Change | - | -31.4% | -31.42% | -21.91% | -27.87% | 7.44% | - | - |
| Enterprise Value (EV) 1 | 1,273 | 598.2 | 550.8 | 449.5 | 335.7 | 391.3 | 382 | 371 |
| Change | - | -52.99% | -7.92% | -18.39% | -25.31% | 16.54% | -2.38% | -2.86% |
| P/E | 38.8x | -3.79x | 94.2x | 35.9x | 138x | 123x | 23.4x | 17.2x |
| PBR | 1.7x | 0.88x | 1.79x | 1.42x | 1.05x | 1.16x | 1.11x | 1.07x |
| PEG | - | 0x | -1x | 0x | -1.7x | 5.7x | 0x | 0.5x |
| Capitalization / Revenue | 1.08x | 2.11x | 1.54x | 1.26x | 0.91x | 0.91x | 0.89x | 0.85x |
| EV / Revenue | 1.33x | 1.77x | 1.74x | 1.49x | 1.11x | 1.21x | 1.15x | 1.07x |
| EV / EBITDA | 9.42x | 5.01x | 8.78x | 7.75x | 6.73x | 7.4x | 6.72x | 5.99x |
| EV / EBIT | 15.1x | 23.8x | 12.8x | 11.2x | 10.5x | 11.5x | 9.86x | 8.52x |
| EV / FCF | 51.5x | 24.6x | 32.2x | 32.6x | 22.7x | 20.4x | 20.9x | 15.6x |
| FCF Yield | 1.94% | 4.06% | 3.1% | 3.07% | 4.41% | 4.89% | 4.78% | 6.42% |
| Dividend per Share 2 | 0.06 | 0.033 | 0.036 | 0.043 | 0.034 | 0.0232 | 0.0256 | 0.0298 |
| Rate of return | 1.74% | 1.4% | 2.12% | 3.23% | 3.52% | 2.23% | 2.45% | 2.86% |
| EPS 2 | 0.089 | -0.624 | 0.018 | 0.037 | 0.007 | 0.0085 | 0.0445 | 0.0607 |
| Distribution rate | 67.4% | -5.29% | 200% | 116% | 486% | 274% | 57.4% | 49.1% |
| Net sales 1 | 959.7 | 337.9 | 316.3 | 302.4 | 302 | 324.3 | 333.4 | 348.3 |
| EBITDA 1 | 135.1 | 119.5 | 62.7 | 58 | 49.9 | 52.84 | 56.88 | 61.97 |
| EBIT 1 | 84 | 25.1 | 43.2 | 40.1 | 32 | 34.08 | 38.73 | 43.55 |
| Net income 1 | 26.9 | -183.8 | 5.4 | 10.6 | 2.1 | 2.2 | 13.39 | 16.67 |
| Net Debt 1 | 234.7 | -113.8 | 62.5 | 68.2 | 60.7 | 95.76 | 86.47 | 75.54 |
| Reference price 2 | 3.450 | 2.365 | 1.696 | 1.330 | 0.966 | 1.042 | 1.042 | 1.042 |
| Nbr of stocks (in thousands) | 300,821 | 301,047 | 287,918 | 286,708 | 284,712 | 283,587 | - | - |
| Announcement Date | 3/18/22 A | 3/29/23 A | 3/19/24 A | 3/19/25 A | 3/17/26 A | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 122.59x | 1.21x | 7.4x | 2.23% | 398M | |
| 16.08x | - | - | - | 14.69B | |
| 22.5x | 2.8x | 12.26x | 2.03% | 9.86B | |
| 289.51x | 62.02x | 208.13x | 0.12% | 8.24B | |
| 23.94x | 2.31x | 10.25x | -.--% | 7.11B | |
| 19.13x | 1.73x | 10.18x | 2.12% | 6.34B | |
| 79.07x | 25.72x | 64.97x | 0.28% | 5.46B | |
| 97.85x | 7.68x | 34.2x | 0.39% | 3.65B | |
| 36.48x | 3.82x | 17.71x | 0.94% | 3.34B | |
| 19.2x | - | - | - | 2.45B | |
| Average | 72.63x | 13.41x | 45.64x | 1.01% | 6.15B | |
| Weighted average by Cap. | 67.31x | 16.85x | 56.66x | 0.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ESNT Stock
- Valuation Essentra plc
Select your edition
All financial news and data tailored to specific country editions
